Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at BioCentury’s NewsMakers in the Biotech Industry Conference at 1:30 pm EDT/10:30 am PDT on Friday, September 27, 2013, in New York. During the presentation, Dr. Morrissey will review the company’s development plans and priorities for cabozantinib in 2013. He will also discuss the company’s corporate strategy and financial outlook, and provide a general business update.
Help employers find you! Check out all the jobs and post your resume.
